Processa Pharmaceuticals, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q1 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Processa Pharmaceuticals, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q1 2022 to Q1 2023.
  • Processa Pharmaceuticals, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending March 31, 2023 was $0.000.
  • Processa Pharmaceuticals, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $0.000.
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.